CSL Vifor & Sucroferric oxyhydroxide - Unionpedia, the concept map

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between CSL Vifor and Sucroferric oxyhydroxide

CSL Vifor vs. Sucroferric oxyhydroxide

CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD).

Chronic kidney disease

Chronic kidney disease (CKD) is a type of long-term kidney disease, in which either there is a gradual loss of kidney function occurs over a period of months to years, or abnormal kidney structure (with normal function).

CSL Vifor and Chronic kidney disease · Chronic kidney disease and Sucroferric oxyhydroxide · See more »

Kidney dialysis

Kidney dialysis (from Greek,, 'dissolution'; from,, 'through', and,, 'loosening or splitting') is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally.

CSL Vifor and Kidney dialysis · Kidney dialysis and Sucroferric oxyhydroxide · See more »